Mobile tele-Ophthalmology Screening Program for Diabetic Retinopathy/ Different Care Models/Care Pathways for Patients with Diabetic Foot Ulcers

COLLABORATIVE PROJECTS

Mobile tele-Ophthalmology Screening Program for Diabetic Retinopathy
There are close to 1.5 million Ontarians living with diabetes and 33% of all Ontarians with diabetes do not get regular eye exams for diabetic retinopathy (DR), while 43% of Ontarians 20 to 64 years old with diabetes is not screened for DR. [7] The impact of a specific province-wide Mobile tele-Ophthalmology screening service, to identify and prevent DR, has not been evaluated and the cost-effectiveness of existing teleophthalmology DR screening programs have demonstrated mixed results. [8-11] Findings from a pilot study have enabled us to estimate fixed and variable costs associated with the Mobile tele-Ophthalmology program. [12] Results from this study noted that DR screening by means of Mobile tele-Ophthalmology is less costly and more effective in screening for the severe vision loss in an at-risk population during the pilot program.

 

We will assess the pan-provincial and potentially pan-Canadian sustainability of the Mobile tele-Ophthalmology screening program both for high-risk populations and the general population diagnosed with diabetes with an average risk to develop DR

Different Care Models/Care Pathways for Patients with Diabetic Foot Ulcers
Building on a previous HTA of different interventions designed for the patients with chronic wounds, we will evaluate the long-term relative effectiveness and cost-effectiveness of new technologies and devices, or services, or care pathways being examined for wound care across Diabetes Action Canada research programs.

Using the evidence generated by the ongoing evaluations, accompanied by with the relevant evidence from the literature, this research will answer the essential HTA question – Should the public payer fund a new care pathway for patients with diabetic foot ulcers? Evidence-based adoption of any new care pathway (similar to purchasing new technology) within Ontario’s or any other provincial health care system will require evidence of safety, effectiveness and cost-effectiveness.


Stay updated with News and Events